Anlon Healthcare Q2 FY27 consolidated revenue Rs 105.61 cr; PAT Rs 17.18 cr
Anlon Healthcare’s consolidated Q2 FY27 revenue rose to Rs 105.61 cr and PAT to Rs 17.18 cr versus Rs 52.20 cr and Rs 9.32 cr in Q2 FY26.
Key takeaways
- Rs 105.61 cr consolidated revenue from operations in Q2 FY27 vs Rs 52.20 cr in Q2 FY26
- Rs 25.24 cr consolidated EBITDA in Q2 FY27 vs Rs 13.71 cr in Q2 FY26
- Rs 17.18 cr consolidated PAT in Q2 FY27 vs Rs 9.32 cr in Q2 FY26
- Consolidated EPS was 0.32 in Q2 FY27 compared with 0.18 in Q2 FY26
- Purchase of Services was Rs 72.88 cr in Q2 FY27 vs Rs 32.96 cr in Q2 FY26
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 105.61 cr | Rs 52.20 cr | +102.3% |
| PAT | Rs 17.18 cr | Rs 9.32 cr | +84.4% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 16.27% of revenue, down 158 bps from 17.85%.
• Revenue from operations (Q2 FY27, consolidated): Rs 105.61 cr (Q2 FY26: Rs 52.20 cr)
• EBITDA (Q2 FY27, consolidated): Rs 25.24 cr (Q2 FY26: Rs 13.71 cr)
• Profit before tax (Q2 FY27, consolidated): Rs 23.48 cr (Q2 FY26: Rs 12.45 cr)
• Profit after tax (Q2 FY27, consolidated): Rs 17.18 cr (Q2 FY26: Rs 9.32 cr)
• EPS (Q2 FY27, consolidated): 0.32 (Q2 FY26: 0.18)
• Total expenses – represented as Purchase of Services plus Employee Expenses plus Other Expenses and other P&L items – are not given as a single line in the consolidated quarterly income statement.
According to the consolidated quarterly income statement in the investor presentation’s statement of financial results, Anlon Healthcare Limited reported a sharp year-on-year increase in scale in Q2 FY27. Revenue from operations for the quarter ended 30 September 2026 was Rs 105.61 cr, compared with Rs 52.20 cr in the corresponding quarter a year earlier. EBITDA for Q2 FY27 was Rs 25.24 cr versus Rs 13.71 cr in Q2 FY26. Profit before tax rose to Rs 23.48 cr from Rs 12.45 cr over the same period.
Profit after tax for Q2 FY27 came in at Rs 17.18 cr, up from Rs 9.32 cr in Q2 FY26, as shown in the statement of financial results. The company reported EPS of 0.32 for Q2 FY27, compared with 0.18 in Q2 FY26.
On a half-year basis, the same consolidated income statement shows revenue from operations of Rs 193.17 cr for H1 FY27 against Rs 85.50 cr in H1 FY26. EBITDA for H1 FY27 was Rs 40.83 cr versus Rs 19.95 cr a year earlier. Profit before tax for H1 FY27 stood at Rs 37.13 cr compared with Rs 17.45 cr in H1 FY26, while profit after tax was Rs 25.46 cr versus Rs 12.86 cr.
The consolidated quarterly income statement also discloses key cost and operating lines. Purchase of Services was Rs 72.88 cr in Q2 FY27 versus Rs 32.96 cr in Q2 FY26. Employee Expenses were Rs 2.59 cr in Q2 FY27 (Q2 FY26: Rs 1.06 cr), and Other Expenses were Rs 4.90 cr (Q2 FY26: Rs 4.47 cr). Depreciation for the quarter was Rs 0.95 cr (Q2 FY26: Rs 0.452 cr), while Finance Cost was Rs 0.862 cr (Q2 FY26: Rs 0.838 cr). Tax expense for Q2 FY27 was Rs 6.30 cr, compared with Rs 3.13 cr in Q2 FY26.
All figures above are taken from the consolidated quarterly income statement in the statement of financial results within the investor presentation.
Track Anlon Healthcare Ltd
Cruxal reads every Anlon Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
